This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
1A Comas-Herrera , R Wittenberg , L Pickard , M Knapp . Cognitive impairment in older people: future demand for long-term care services and the associated costs. Int J Geriatr Psychiatry 2007; 22: 1037–45.
3C Spearman . ‘General intelligence’ objectively determined and measured. Am J Psychol 1904; 15: 201–93.
6IJ Deary . Human intelligence differences: a recent history. Trends Cogn Sci 2001; 5: 127–30.
7JJ Jones , P van Schaik , P Witts . A factor analysis of the Wechsler Adult Intelligence Scale 3rd Edition (WAIS-III) in a low IQ sample. Br J Clin Psychol 2006; 45: 145–52.
8B Devlin , M Daniels , K Roeder . The heritability of IQ. Nature 1997; 388: 468–71.
9TJ Jr Bouchard , M McGue . Genetic and environmental influences on human psychological differences. J Neurobiol 2003; 54: 4–45.
10L Qi , YA Cho . Gene–environment interaction and obesity. Nutr Rev 2008; 66: 684–94.
11TE Thorgeirsson , F Geller , P Sulem A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 2008; 452: 638–42.
12JH Kim , PE Elwood , MI Asher . Diet and asthma: looking back, moving forward. Respir Res 2009; 10: 49.
13A Caspi , B Williams , J Kim-Cohen Moderation of breastfeeding effects on the IQ by genetic variation in fatty acid metabolism. Proc Natl Acad Sci USA 2007; 104: 18860–65.
14FT Wang , H Hu , J Schwartz Modifying effects of the HFE polymorphisms on the association between lead burden and cognitive decline. Environ Health Perspect 2007; 115: 1210–15.
15E Morales , J Sunyer , F Castro-Giner Influence of glutathione S-transferase polymorphisms on cognitive functioning effects induced by p, p’-DDT among preschoolers. Environ Health Perspect 2008; 116: 1581–15.
16W Johnson , SE Harris , JM Starr , LJ Whalley , IJ Deary . PPARG Pro12Ala genotype and risk of cognitive decline in elders? Maybe with diabetes. Neurosci Lett 2008; 434: 50–55.
17M. Ridley Nature via Nurture. Harper Collins, New York, 2003.
18GE McClearn , B Johansson , S Berg , NL Pedersen , F Ahern , SA Petrill , R Plomin . Substantial genetic influence on cognitive abilities in twins 80 or more years old. Science 1997; 276: 1560–63.
19FM Spinath , A Ronald , N Harlaar , TS Price , R Plomin . Phenotypic g early in life: on the etiology of general cognitive ability in a large population sample of twin children aged 2–4 years. Intelligence 2003; 31: 195–210.
20F Giubilei , E Medda , C Fagnani Heritability of neurocognitive functioning in the elderly: evidence from an Italian twin study. Age Ageing 2008; 37: 640–46.
21JS Peper , RM Brouwer , DI Boomsma , RS Kahn , HE Hulshoff . Genetic influences on human brain structure: a review of brain imaging studies in twins. Hum Brain Map 2007; 28: 464–73.
22D Posthuma , WF Baaré , HE Hulshoff Pol , RS Kahn , DI Boomsma , EJ De Geus . Genetic correlations between brain volumes and the WAIS-III dimensions of verbal comprehension, working memory, perceptual organization, and processing speed. Twin Res 2003; 6: 131–39.
25JP Godbout , RW Johnson . Age and neuroinflammation: a lifetime of psychoneuroimmune consequences. Neurol Clin 2006; 24: 521–38.
26DH Mauch , K Nägler , S Schumacher , C Göritz , EC Müller , A Otto , FW Pfrieger . CNS synaptogenesis promoted by glia-derived cholesterol. Science 2001; 294: 1354–57.
27RW Mahley . E Apolipoprotein : cholesterol transport protein with expanding role in cell biology. Science 1988; 240: 622–30.
28BJ Small , CB Rosnick , L Fratiglioni , L Bäckman . Apolipoprotein E and cognitive performance: a meta-analysis. Psychol Aging 2004; 19: 592–600.
29L Bertram , RE Tanzi . Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses. Nature Rev Neurosci 2008; 9: 768–78.
31J Raber , Y Huang , JW Ashford . ApoE genotype accounts for the vast majority of AD risk and AD pathology. Neurobiol Aging 2004; 25: 641–50.
32AS Khachaturian , CD Corcoran , LS Mayer , PP Zandi , JC Breitner . Apolipoprotein E ɛ4 count affects age at onset of Alzheimer's disease, but not lifetime susceptibility: the Cache County Study. Arch Gen Psychiatry 2004; 61: 518–24.
33G Bu . Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy. Nat Rev Neurosci 2009; 10: 333–44.
34BP Nathan , S Bellosta , DA Sanan , KH Weisgraber , RW Mahley , RE Pitas . Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 1994; 264: 850–52.
36B Teter , PT Xu , JR Gilbert , AD Roses , D Galasko , GM Cole . Defective neuronal sprouting by human apolipoprotein E4 is a gain-of negative function. J Neurosci Res 2002; 68: 331–36.
37KC Kutner , DM Erlanger , J Tsai , B Jordan , NR Relkin . Lower cognitive performance of older football players possessing apolipoprotein E ɛ4. Neurosurgery 2000; 47: 651–57.
38BD Jordan , NR Relkin , LD Ravdin , AR Jacobs , A Bennett , S Gandy . Apolipoprotein E ɛ4 associated with chronic traumatic brain injury in boxing. JAMA 1997; 278: 136–40.
39WJ Strittmatter , KH Weisgraber , DY Huang Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer's disease. Proc Natl Acad Sci USA 1993; 90: 8098–102.
40GW Rebeck , JS Reiter , DK Strickland , BT Hyman . Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 1993; 11: 575–80.
41DA Bennett , RS Wilson , JA Schneider Apolipoprotein E ɛ4 allele, AD pathology, and the clinical expression of Alzheimer's disease. Neurology 2003; 60: 246–52.
42T Polvikoski , R Sulkava , M Haltia Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein. N Engl J Med 1995; 333: 1242–47.
43A Drzezga , T Grimmer , G Henriksen Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer's disease. Neurology 2009; 72: 1487–94.
44MA Marques , M Tolar , JA Harmony , KA Crutcher . A thrombin cleavage fragment of apolipoprotein E exhibits isoform-specific neurotoxicity. Neuroreport 1996; 7: 2529–32.
46Y Huang , XQ Liu , T Wyss-Coray , WJ Brecht , DA Sanan , RW Mahley . Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons. Proc Natl Acad Sci USA 2001; 98: 8838–43.
47D Eddins , RC Klein , JL Yakel , ED Levin . Hippocampal infusions of apolipoprotein E peptides induce long-lasting cognitive impairment. Brain Res Bull 2009; 79: 111–15.
48EH Corder , AM Saunders , WJ Strittmatter Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261: 921–23.
49S Bookheimer , A Burggren . APOE-4 genotype and neurophysiological vulnerability to Alzheimer's and cognitive aging. Ann Rev Clin Psychol 2009; 5: 343–62.
51JC Breitner , BW Wyse , JC Anthony APOE-ɛ4 count predicts age when prevalence of AD increases, then declines: the Cache County Study. Neurology 1999; 53: 321–31.
52LA Farrer , LA Cupples , JL Haines Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer's disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 1997; 278: 1349–56.
54IJ Deary , MC Whiteman , A Pattie Cognitive change and the APOE ɛ4 allele. Nature 2002; 418: 932.
57IJ Deary , MC Whiteman , JM Starr , LJ Whalley , HC Fox . The impact of childhood intelligence on later life: following up the Scottish mental Surveys of 1932 and 1947. J Pers Soc Psychol 2004; 86: 130–47.
58SG Mueller , N Schuff , S Raptentsetsang , J Elman , MW Weiner . Selective effect of Apo e4 on CA3 and dentate in normal aging and Alzheimer's disease using high resolution MRI at 4 T. Neuroimage 2008; 42: 42–48.
59G Bartzokis , PH Lu , DH Geschwind Apolipoprotein E affects both myelin breakdown and cognition: implications for age-related trajectories of decline into dementia. Biol Psychiatry 2007; 62: 1380–87.
60AC Burggren , MM Zeineh , AD Ekstrom , MN Braskie , PM Thompson , GW Small , SY Bookheimer . Reduced cortical thickness in hippocampal subregions among cognitively normal apolipoprotein E e4 carriers. Neuroimage 2008; 41: 1177–83.
61TN Tombaugh , NJ McIntyre . The mini-mental state examination: a comprehensive review. J Am Geriatr Soc 1992; 40: 922–35.
62P Rabbitt , C Lowe . Patterns of cognitive ageing. Psychol Res 2000; 63: 308–16.
63D Finkel , CA Reynolds , JJ McArdle , NL Pedersen . Age changes in processing speed as a leading indicator of cognitive aging. Psychol Aging 2007; 22: 558–68.
64P Rabbitt , P Diggle , F Holland , L McInnes . Practice and drop-out effects during a 17-year longitudinal study of cognitive aging. J Gerontol B Psychol Sci Soc Sci 2004; 59: 84–97.
65J Savitz , M Solms , R Ramesar . Apolipoprotein E variants and cognition in healthy individuals: a critical opinion. Brain Res Rev 2006; 51: 125–35.
66CJ Packard , RG Westendorp , DJ Stott Prospective study of pravastatin in the elderly at risk group. Association between apolipoprotein E4 and cognitive decline in elderly adults. J Am Geriatr Soc 2007; 55: 1777–85.
67JW Cargin , P Maruff , A Collie , R Shafiq-Antonacci , C Masters . Decline in verbal memory in non-demented older adults. J Clin Exp Neuropsychol 2007; 29: 706–18.
68LA Tupler , KR Krishnan , DL Greenberg Predicting memory decline in normal elderly: genetics, MRI, and cognitive reserve. Neurobiol Aging 2007; 28: 1644–56.
69H Christensen , PJ Batterham , AJ Mackinnon The association of APOE genotype and cognitive decline in interaction with risk factors in a 65–69 year old community sample. BMC Geriatr 2008; 8: 14.
72RJ Caselli , AC Dueck , D Osborne Longitudinal modeling of age-related memory decline and the APOE ɛ4 effect. N Engl J Med 2009; 361: 255–63.
73P van Vliet , AM Oleksik , SP Mooijaart , AJ de Craen , RG Westendorp . APOE genotype modulates the effect of serum calcium levels on cognitive function in old age. Neurology 2009; 72: 821–28.
74Z Nagy , MM Esiri , KA Jobst , C Johnston , S Litchfield , E Sim , AD Smith . Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease. Neuroscience 1995; 69: 757–61.
75TG Ohm , M Kirca , J Bohl , H Scharnagl , W Gross , W März . Apolipoprotein E polymorphism influences not only cerebral senile plaque load but also Alzheimer-type neurofibrillary tangle formation. Neuroscience 1995; 66: 583–87.
76N Cherbuin , LS Leach , H Christensen , KJ Anstey . Neuroimaging and APOE genotype: a systematic qualitative review. Dement Geriatr Cogn Disord 2007; 24: 348–62.
77C Marra , A Bizzarro , A Daniele Apolipoprotein E ɛ4 allele differently affects the patterns of neuropsychological presentation in early- and late-onset Alzheimer's disease patients. Dement Geriatr Cogn Disord 2004; 18: 125–31.
78LC Lam , NL Tang , SL Ma , VW Lui , AS Chan , PY Leung , HF Chiu . Apolipoprotein ɛ-4 allele and the two-year progression of cognitive function in Chinese subjects with late-onset Alzheimer's disease. Am J Alzheimers Dis Other Demen 2006; 21: 92–99.
79S Cosentino , N Scarmeas , E Helzner , MM Glymour , J Brandt , M Albert , D Blacker , Y Stern . APOE ɛ4 allele predicts faster cognitive decline in mild Alzheimer's disease. Neurology 2008; 70: 1842–49.
81JC Morris , S Edland , C Clark The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease. Neurology 1993; 43: 2457–65.
83BL Plassman , JC Breitner . Apolipoprotein E and cognitive decline in Alzheimer's disease. Neurology 1996; 47: 317–20.
85H Basun , M Grut , B Winblad , L Lannfelt . Apolipoprotein ɛ4 allele and disease progression in patients with late-onset Alzheimer's disease. Neurosci Lett 1995; 183: 32–34.
86T Asada , T Kariya , Z Yamagata , T Kinoshita , A Asaka . ApoE ɛ4 allele and cognitive decline in patients with Alzheimer's disease. Neurology 1996; 47: 603.
87C Holmes , R Levy , DM McLoughlin , JF Powell , S Lovestone . Apolipoprotein E: non-cognitive symptoms and cognitive decline in late onset Alzheimer's disease. J Neurol Neurosurg Psychiatry 1996; 61: 580–83.
88G Dal Forno , DX Rasmusson , J Brandt , KA Carson , R Brookmeyer , J Troncoso , CH Kawas . Apolipoprotein E genotype and rate of decline in probable Alzheimer's disease. Arch Neurol 1996; 53: 345–50.
89A Kurz , R Egensperger , M Haupt , N Lautenschlager , B Romero , MB Graeber , U Müller . Apolipoprotein E ɛ4 allele, cognitive decline, and deterioration of everyday performance in Alzheimer's disease. Neurology 1996; 47: 440–43.
90JH Growdon , JJ Locascio , S Corkin , T Gomez-Isla , BT Hyman . Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease. Neurology 1996; 47: 444–48.
92C Jonker , B Schmand , J Lindeboom , LM Havekes , LJ Launer . Association between apolipoprotein E ɛ4 and the rate of cognitive decline in community-dwelling elderly individuals with and without dementia. Arch Neurol 1998; 55: 1065–69.
93M Lehtovirta , J Kuikka , S Helisalmi Longitudinal SPECT study in Alzheimer's disease: relation to apolipoprotein E polymorphism. J Neurol Neurosurg Psychiatry 1998; 64: 742–46.
94MR Farlow , PA Cyrus , A Nadel , DK Lahiri , A Brashear , B Gulanski . Metrifonate treatment of AD: influence of APOE genotype. Neurology 1999; 53: 2010–16.
95AJ Slooter , JJ Houwing-Duistermaat , F van Harskamp Apolipoprotein E genotype and progression of Alzheimer's disease: the Rotterdam Study. J Neurol 1999; 246: 304–8.
96J Aerssens , P Raeymaekers , S Lilienfeld , H Geerts , F Konings , W Parys . APOE genotype: no influence on galantamine treatment efficacy nor on rate of decline in Alzheimer's disease. Dement Geriatr Cogn Disord 2001; 12: 69–77.
97E Mori , K Lee , M Yasuda , M Hashimoto , H Kazui , N Hirono , M Matsui . Accelerated hippocampal atrophy in Alzheimer's disease with apolipoprotein E ɛ4 allele. Ann Neurol 2002; 51: 209–14.
98T Kleiman , K Zdanys , B Black Apolipoprotein E ɛ4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis. Dement Geriatr Cogn Disord 2006; 22: 73–82.
100L Bracco , C Piccini , M Baccini Pattern and progression of cognitive decline in Alzheimer's disease: role of premorbid intelligence and ApoE genotype. Dement Geriatr Cogn Disord 2007; 24: 483–91.
101S Craft , L Teri , SD Edland Accelerated decline in apolipoprotein E-ɛ4 homozygotes with Alzheimer's disease. Neurology 1998; 51: 149–53.
102M Kanai , M Shizuka , K Urakami , E Matsubara , Y Harigaya , K Okamoto , M Shoji . Apolipoprotein E4 accelerates dementia and increases cerebrospinal fluid tau levels in Alzheimer's disease. Neurosci Lett 1999; 267: 65–68.
103N Hirono , M Hashimoto , M Yasuda , H Kazui , E Mori . Accelerated memory decline in Alzheimer's disease with apolipoprotein ɛ4 allele. J Neuropsychiatry Clin Neurosci 2003; 15: 354–58.
104CA Martins , A Oulhaj , CA de Jager , JH Williams . APOE alleles predict the rate of cognitive decline in Alzheimer's disease: a non-linear model. Neurology 2005; 65: 1888–93.
105GB Frisoni , S Govoni , C Geroldi , A Bianchetti , L Calabresi , G Franceschini , M Trabucchi . Gene dose of the ɛ4 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer's disease. Ann Neurol 1995; 37: 596–604.
106Y Stern , J Brandt , M Albert , DM Jacobs , X Liu , K Bell , K Marder , M Sano , S Albert , C Del-Castillo Castenada , F Bylsma , B Tycko , R Mayeux . The absence of an apolipoprotein ɛ4 allele is associated with a more aggressive form of Alzheimer's disease. Ann Neurol 1997; 41: 615–20.
107BD Hoyt , PJ Massman , C Schatschneider , N Cooke , RS Doody . Individual growth curve analysis of APOE ɛ4-associated cognitive decline in Alzheimer's disease. Arch Neurol 2005; 62: 454–59.